Coloplast A/S Stock price

Equities

COLO B

DK0060448595

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe 08:34:28 2024-02-22 am EST 5-day change 1st Jan Change
903.2 DKK +1.64% Intraday chart for Coloplast A/S +1.71% +16.84%
Sales 2024 * 27.29B 3.98B Sales 2025 * 29.66B 4.33B Capitalization 200B 29.11B
Net income 2024 * 5.37B 784M Net income 2025 * 6.2B 904M EV / Sales 2024 * 7.99 x
Net Debt 2024 * 18.41B 2.68B Net Debt 2025 * 17.68B 2.58B EV / Sales 2025 * 7.33 x
P/E ratio 2024 *
37 x
P/E ratio 2025 *
32 x
Employees 15,751
Yield 2024 *
2.32%
Yield 2025 *
2.51%
Free-Float 58.32%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.02%
1 week+1.22%
Current month+12.54%
1 month+15.34%
3 months+16.42%
6 months+11.50%
Current year+16.27%
More quotes
1 week
870.00
Extreme 870
901.00
1 month
764.00
Extreme 764
902.40
Current year
757.80
Extreme 757.8
902.40
1 year
689.20
Extreme 689.2
993.00
3 years
689.20
Extreme 689.2
1 194.00
5 years
632.20
Extreme 632.2
1 194.00
10 years
407.00
Extreme 407
1 194.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 07-12-31
Director of Finance/CFO 52 05-12-31
Chairman 64 87-12-31
Members of the board TitleAgeSince
Director/Board Member 76 68-09-30
Director/Board Member 59 17-11-30
Chairman 64 87-12-31
More insiders
Date Price Change Volume
24-02-22 902 +1.51% 47 084
24-02-21 888.6 +0.34% 222,366
24-02-20 885.6 +0.05% 156,830
24-02-19 885.2 -0.98% 234,789
24-02-16 894 +0.81% 321,886

Delayed Quote Nasdaq Copenhagen, February 22, 2024 at 04:54 am EST

More quotes
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (44.6%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (38.2%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (5.3%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.3%), the United States (18.9%), the United Kingdom (13.7%), France (10.9%) and other (55.2%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
888.6 DKK
Average target price
857.8 DKK
Spread / Average Target
-3.46%
Consensus
  1. Stock
  2. Equities
  3. Stock Coloplast A/S - Nasdaq Copenhagen
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer